• DOI:10.1007/s10096-013-1915-8
Corpus ID: 11317427

Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment

@article{Gullo2013CryptococcosisEF,
  title={Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment},
  author={F. P. Gullo and S. A. Rossi and J. Sardi and V. L. I. Teodoro and M. J. Mendes-Giannini and A. M. Fusco-Almeida},
  journal={European Journal of Clinical Microbiology & Infectious Diseases},
  year={2013},
  volume={32},
  pages={1377-1391}
}

F. P. Gullo, S. A. Rossi, +3 authors A. M. Fusco-Almeida

Published 2013

Biology, Medicine

European Journal of Clinical Microbiology & Infectious Diseases

Cryptococcosis is an important systemic mycosis and the third most prevalent disease in human immunodeficiency virus (HIV)-positive individuals. The incidence of cryptococcosis is high among the 25 million people with HIV/acquired immunodeficiency syndrome (AIDS), with recent estimates indicating that there are one million cases of cryptococcal meningitis globally per year in AIDS patients. In Cryptococcus neoformans, resistance to azoles may be associated with alterations in the target enzyme… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed